Access cutting-edge breast cancer treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central review (BICR) in the HR+, HER2-low (immunohistochemistry \[IHC\]2+/in situ hybridization \[ISH\]- and IHC 1+) population.
Sponsor: DualityBio Inc.
Check if you qualify for this breast cancer clinical trial in Orange, CA
If you're searching for breast cancer treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.